liron caplan

Dr. Caplan’s major interest is in pharmacoepidemiology and he has focused on the toxicities of therapies for rheumatoid arthritis (including use of steroids) as well as the development of autoimmune pulmonary disease. His expertise extends to use of large administrative datasets and the creation of registries. He has worked with the National Data Bank for Rheumatic Diseases, and is an investigator with the Veterans Affairs Rheumatoid Arthritis registry and the Program to Understand the Longterm Outcomes in SpondyloARthritis (PULSAR) registry.